Solid Tumors: AZD9592 Treatment Study

We are testing a new drug called AZD9592 for patients with solid tumors. The goal is to learn more about its safety and how it may help in treating cancer.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Regional De Marseille
Centre d'essais en cancérologie de Marseille
Marseille, France
Centre De Lutte Contre Le Cancer Eugene Marquis
Recherche Clinique en Pneumologie
Rennes, France
Institut Gustave Roussy
Department of Medical oncology
Villejuif, France

Sponsor: Astrazeneca AB
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.